References

Anderson S, Bankier AT, Barrell BG, de Bruijn MH, Coulson AR, Drouin J, Eperon IC, Nierlich DP, Roe BA, Sanger F, Schreier PH, Smith AJ, Staden R, Young IG (198l) Sequence and organization of the human mitochondrial genome. Nature 290(5806): 457-465.

Andrews RM, Kubacka I, Chinnery PF, Lightowlers RN, Turnbull DM, Howell N (1999) Reanalysis and revision of the Cambridge Reference Sequence for human mitochondrial DNA. Nature Genetics 23(2): 147.

Attardi G (2002) Role of mitochondrial DNA in human aging. Mitochondrion 2: 27-37.

Coller HA, Khrapko K, Bodyak ND, Nekhaeva E, Herrero-Jimenez P, Thilly WG (2001) High frequency of homoplasmic mitochondrial DNA mutations in human tumors can be explained without selection. Nat Genet 28(2): 147-150.

de Mendoza C, Sanchez-Conde M, Ribera E, Domingo P, Soriano V (2004) Could mitochondrial DNA quantitation be a surrogate marker for drug mitochondrial toxicity? AIDS Rev 6(3): 169-180.

Fayet G, Jansson M, Sternberg D, Moslemi AR, Blondy P, Lombes A, Fardeau M, Oldfors A (2002) Ageing muscle: clonal expansions of mitochondrial DNA point mutations and deletions cause focal impairment of mitochondrial function. Neuromuscul Disord 12(5): 484-493.

Hoy JF, Gahan ME, Carr A, Smith D, Lewin SR, Wesselingh S, Cooper DA (2004) Changes in mitochondrial DNA in peripheral blood mononuclear cells from HIV-infected patients with lipoatrophy randomized to receive abacavir. J Infect Dis 190(4): 688-692.

Lewis W, Day BJ, Copeland WC (2003) Mitochondrial toxicity of NRTI antiviral drugs: an integrated cellular perspective. Nat Rev Drug Discov 2(10): 812-822.

McComsey G, Bai RK, Maa JF, Seekins D, Wong LJ (2005a) Extensive investigations of mitochondrial DNA genome in treated HIV-infected subjects: beyond mitochondrial DNA depletion. J Acquir Immune Defic Syndr 39(2): 181-188.

McComsey GA, Paulsen DM, Lonergan JT, Hessenthaler SM, Hoppel CL, Williams VC, Fisher RL, Cherry CL, White-Owen C, Thompson KA, Ross ST, Hernandez JE, Ross LL (2005b) Improvements in lipoatrophy, mitochondrial DNA levels and fat apoptosis after replacing stavudine with abacavir or zidovudine. Aids 19(1): 15-23.

Michikawa Y, Laderman K, Richter K, Attardi G (1999a) Role of nuclear background and in vivo environment in variable segregation behavior of the aging-dependent T414G mutation at critical control site for human fibroblast mtDNA replication. Somat Cell Mol Genet 25(5-6): 333-342.

Michikawa Y, Mazzucchelli F, Bresolin N, Scarlato G, Attardi G (1999b) Aging-dependent large accumulation of point mutations in the human mtDNA control region for replication. Science 286(5440): 774-779.

MITOMAP (2005) A Human Mitochondrial Genome Database. http://www. mitomap.org

Penta JS, Johnson FM, Wachsman JT, Copeland WC (2001) Mitochondrial DNA in human malignancy. Mutat Res 488(2): 119-133.

Spinazzola A, Zeviani M (2005) Disorders of nuclear-mitochondrial intergenomic signaling. Gene 18: 162-168.

Szuhai K, Ouweland J, Dirks R, Lemaitre M, Truffert J, Janssen G, Tanke H, Holme E, Maassen J, Raap A (2001) Simultaneous A8344G heteroplasmy and mitochon-drial DNA copy number quantification in myoclonus epilepsy and ragged-red fibers (MERRF) syndrome by a multiplex molecular beacon based real-time fluorescence PCR. Nucleic Acids Res 29(3): E13.

Woischnik M, Moraes CT (2002) Pattern of organization of human mitochondrial pseudogenes in the nuclear genome. Genome Res 12(6): 885-893.

Zuker M (2003) Mfold web server for nucleic acid folding and hybridization prediction. Nucleic Acids Res 31(13): 3406-3415.

Was this article helpful?

0 0

Post a comment